AEON Biopharma, Inc. (AEON) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$12.80M | -117.5% |
| 2024 | $72.98M | — |
| 2022 | -$48.43M | -2401.6% |
| 2021 | -$1.94M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$12.80M | -117.5% |
| 2024 | $72.98M | — |
| 2022 | -$48.43M | -2401.6% |
| 2021 | -$1.94M | — |